[1]
“Hypertension as a Cardiovascular Toxicity of Bruton’s Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia”, Can Hematol Today, vol. 4, no. s03, pp. 2–12, May 2025, doi: 10.58931/cht.2025.4s0368.